Redox buffering by melanin and Fe(II) in Cryptococcus neoformans.
Melanin is a fungal extracellular redox buffer which, in principle, can neutralize antimicrobial oxidants generated by immunologic effector cells, but its source of reducing equivalents is not known. We wondered whether Fe(II) generated by the external ferric reductase of fungi might have the physiologic function of reducing fungal melanin and thereby promoting pathogenesis. We observed that exposure of a melanin film electrode to reductants decreased the open-circuit potential (OCP) and reduced the area of a cyclic voltammetric reduction wave whereas exposure to oxidants produced the opposite effects. Exposure to 10, 100, 1,000 or 10,000 microM Fe(II) decreased the OCP of melanin by 0.015, 0.038, 0.100, and 0.120 V, respectively, relative to a silver-silver chloride standard, and decreased the area of the cyclic voltammetric reduction wave by 27, 35, 50, and 83%, respectively. Moreover, exposure to Fe(II) increased the buffering capacity by 44%, while exposure to millimolar dithionite did not increase the buffering capacity. The ratio of the amount of bound iron to the amount of the incremental increase in the following oxidation wave was approximately 1.0, suggesting that bound iron participates in buffering. Light absorption by melanin suspensions was decreased 14% by treatment with Fe(II), consistent with reduction of melanin. Light absorption by suspensions of melanized Cryptococcus neoformans was decreased 1.3% by treatment with Fe(II) (P < 0.05). Cultures of C. neoformans generated between 2 and 160 microM Fe(II) in culture supernatant, depending upon the strain and the conditions [the higher values were achieved by a constitutive ferric reductase mutant in high concentrations of Fe(III)]. We infer that Fe(II) can reduce melanin under physiologic conditions; moreover, it binds to melanin and cooperatively increases redox buffering. The data support a model for physiologic redox cycling of fungal melanin, whereby electrons exported by the yeast to form extracellular Fe(II) maintain the reducing capacity of the extracellular redox buffer.
Jacobson
E S
ES
Hunter Holmes McGuire Veterans Affairs Medical Center, Richmond, Virginia 23249, USA. jacobson.eric_s@richmond.va.gov
Hong
J D
JD
D015095:3-Hydroxyanthranilic Acid / Q000737:chemistry; D003455:Cryptococcus neoformans / Q000737:chemistry*; D004227:Dithionite; D004563:Electrochemistry; D005290:Ferric Compounds / Q000737:chemistry; D005296:Ferrous Compounds / Q000737:chemistry*; D007656:Ketoglutaric Acids / Q000737:chemistry; D008543:Melanins / Q000737:chemistry*; D016877:Oxidants / Q000494:pharmacology; D010084:Oxidation-Reduction; D019163:Reducing Agents / Q000494:pharmacology
D005290:Ferric Compounds; D005296:Ferrous Compounds; D007656:Ketoglutaric Acids; D008543:Melanins; D016877:Oxidants; D019163:Reducing Agents; D004227:Dithionite; D015095:3-Hydroxyanthranilic Acid